<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Scar signal quantification using late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement cardiac magnetic resonance (LGE-CMR) identifies patients at higher risk of future events, both in ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (ICM) and nonischemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (<z:chebi fb="20" ids="15767">DCM</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, the ability of scar signal burden to predict events in such patient groups at the time of referral for implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) has not been well explored </plain></SENT>
<SENT sid="2" pm="."><plain>This study evaluates the predictive use of multiple scar quantification measures in ICM and <z:chebi fb="20" ids="15767">DCM</z:chebi> patients being referred for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: One hundred twenty-four consecutive patients referred for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy (59 with ICM and 65 with <z:chebi fb="20" ids="15767">DCM</z:chebi>) underwent a standardized LGE-CMR protocol with blinded, multithreshold scar signal quantification and, for those with ICM, peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> signal quantification </plain></SENT>
<SENT sid="4" pm="."><plain>Patients were followed prospectively for the primary combined outcome of appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy, survived <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo>, or <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>At a mean follow-up of 632 Â± 262 days, 18 patients (15%) had suffered the primary outcome </plain></SENT>
<SENT sid="6" pm="."><plain>Total scar was significantly higher among those suffering a primary outcome, a relationship maintained within each <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> cohort (P&lt;0.01 for <z:hpo ids='HP_0000001'>all</z:hpo> comparisons) </plain></SENT>
<SENT sid="7" pm="."><plain>Total scar was the strongest independent predictor of the primary outcome and demonstrated a negative predictive value of 86% </plain></SENT>
<SENT sid="8" pm="."><plain>In the ICM subcohort, peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> signal showed only a nonsignificant trend toward elevation among those having a primary end point </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Myocardial scar quantification by LGE-CMR predicts arrhythmic events in patients being evaluated for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> eligibility irrespective of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> etiology </plain></SENT>
</text></document>